Marla Danielle Lipsyc-Sharf
|
|
| Title(s) | HS Clinical Instructor, Medicine |
|---|
| School | Medicine |
|---|
| vCard | Download vCard |
|---|
|
|
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer. J Clin Oncol. 2024 Jan 08; JCO2301071.
Morganti S, Gibson CJ, Jin Q, Santos K, Patel A, Wilson A, Merrill M, Vincuilla J, Stokes S, Lipsyc-Sharf M, Parker T, King TA, Mittendorf EA, Curigliano G, Hughes ME, Stover DG, Tolaney SM, Weeks LD, Tayob N, Lin NU, Garber JE, Miller PG, Parsons HA. PMID: 38190580.
View in:
PubMed Mentions: Fields:
-
Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival. JAMA Netw Open. 2023 10 02; 6(10):e2339584.
Lipsyc-Sharf M, Ballman KV, Campbell JD, Muss HB, Perez EA, Shulman LN, Carey LA, Partridge AH, Warner ET. PMID: 37878313; PMCID: PMC10600583.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Fertility and Sexual Health in Young Women with Early-Stage Breast Cancer. Surg Oncol Clin N Am. 2023 10; 32(4):747-759.
Lipsyc-Sharf M, Partridge AH. PMID: 37714641.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. JCO Precis Oncol. 2023 06; 7:e2300076.
Lipsyc-Sharf M, Jain E, Collins LC, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, Come SE, Peppercorn JM, Borges VF, Warner E, Snow C, Krop IE, Kim D, Weiss J, Zanudo JGT, Partridge AH, Wagle N, Waks AG. PMID: 37364233.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Clinical and translational relevance of intratumor heterogeneity. Trends Cancer. 2023 09; 9(9):726-737.
Goyette MA, Lipsyc-Sharf M, Polyak K. PMID: 37248149; PMCID: PMC10524913.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Elacestrant: who are optimal candidates for the first oral SERD? Ann Oncol. 2023 05; 34(5):449-451.
Lipsyc-Sharf M, Tolaney SM. PMID: 36813113.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
A Shear Decline. N Engl J Med. 2022 11 03; 387(18):1700-1706.
Lipsyc-Sharf M, Connell NT, Ostrominski JW, Levy BD, Loscalzo J. PMID: 36322848.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. J Clin Oncol. 2022 08 01; 40(22):2408-2419.
Lipsyc-Sharf M, de Bruin EC, Santos K, McEwen R, Stetson D, Patel A, Kirkner GJ, Hughes ME, Tolaney SM, Partridge AH, Krop IE, Knape C, Feger U, Marsico G, Howarth K, Winer EP, Lin NU, Parsons HA. PMID: 35658506; PMCID: PMC9467679.
View in:
PubMed Mentions:
22 Fields:
Translation:
Humans
-
Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial. Oncologist. 2022 04 05; 27(4):292-298.
Lipsyc-Sharf M, Ou FS, Yurgelun MB, Rubinson DA, Schrag D, Dakhil SR, Stella PJ, Weckstein DJ, Wender DB, Faggen M, Zemla TJ, Heying EN, Schuetz SR, Noble S, Meyerhardt JA, Bekaii-Saab T, Fuchs CS, Ng K. PMID: 35380713; PMCID: PMC8982431.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCTClinical Trials
-
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405. J Natl Cancer Inst. 2022 03 08; 114(3):427-435.
Lipsyc-Sharf M, Zhang S, Ou FS, Ma C, McCleary NJ, Niedzwiecki D, Chang IW, Lenz HJ, Blanke CD, Piawah S, Van Loon K, Bainter TM, Venook AP, Mayer RJ, Fuchs CS, Innocenti F, Nixon AB, Goldberg R, O'Reilly EM, Meyerhardt JA, Ng K. PMID: 34636852; PMCID: PMC8902338.
View in:
PubMed Mentions:
14 Fields:
Translation:
Humans
-
Total Vitamin D Intake and Risks of Early-Onset Colorectal Cancer and Precursors. Gastroenterology. 2021 10; 161(4):1208-1217.e9.
Kim H, Lipsyc-Sharf M, Zong X, Wang X, Hur J, Song M, Wang M, Smith-Warner SA, Fuchs C, Ogino S, Wu K, Chan AT, Cao Y, Ng K, Giovannucci EL. PMID: 34245763; PMCID: PMC8463427.
View in:
PubMed Mentions:
26 Fields:
Translation:
Humans
-
Evaluation of a Yoga-Based Mind-Body Intervention for Resident Physicians: A Randomized Clinical Trial. Glob Adv Health Med. 2021; 10:21649561211001038.
Loewenthal J, Dyer NL, Lipsyc-Sharf M, Borden S, Mehta DH, Dusek JA, Khalsa SBS. PMID: 33786209; PMCID: PMC7961714.
View in:
PubMed Mentions:
6
-
Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2020 03 01; 26(5):1077-1085.
Datta J, Smith JJ, Chatila WK, McAuliffe JC, Kandoth C, Vakiani E, Frankel TL, Ganesh K, Wasserman I, Lipsyc-Sharf M, Guillem J, Nash GM, Paty PB, Weiser MR, Saltz LB, Berger MF, Jarnagin WR, Balachandran V, Kingham TP, Kemeny NE, Cercek A, Garcia-Aguilar J, Taylor BS, Viale A, Yaeger R, Solit DB, Schultz N, D'Angelica MI. PMID: 31719050; PMCID: PMC7056517.
View in:
PubMed Mentions:
35 Fields:
Translation:
Humans
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs